Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Morphological characterization of systemic changes in KK-Ay mice as an animal model of type 2 diabetes.

Moroki T, Yoshikawa Y, Yoshizawa K, Tsubura A, Yasui H.

In Vivo. 2013 Jul-Aug;27(4):465-72.

PMID:
23812216
[PubMed - indexed for MEDLINE]
2.

Ay allele promotes azoxymethane-induced colorectal carcinogenesis by macrophage migration in hyperlipidemic/diabetic KK mice.

Ito K, Ishigamori R, Mutoh M, Ohta T, Imai T, Takahashi M.

Cancer Sci. 2013 Jul;104(7):835-43. doi: 10.1111/cas.12162. Epub 2013 May 25.

PMID:
23551905
[PubMed - indexed for MEDLINE]
3.

Diabetic nephropathy in KK and KK-Ay mice.

Okazaki M, Saito Y, Udaka Y, Maruyama M, Murakami H, Ota S, Kikuchi T, Oguchi K.

Exp Anim. 2002 Apr;51(2):191-6.

PMID:
12012732
[PubMed - indexed for MEDLINE]
Free Article
4.

[Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice].

Yang CY, Xie ZG, Cheng WB, Jiang X, Chen ZH.

Zhong Yao Cai. 2009 Oct;32(10):1571-6. Chinese.

PMID:
20112724
[PubMed - indexed for MEDLINE]
5.

Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice.

Than S, Ishida H, Inaba M, Fukuba Y, Seino Y, Adachi M, Imura H, Ikehara S.

J Exp Med. 1992 Oct 1;176(4):1233-8.

PMID:
1402665
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Age dependence of glucose tolerance in adult KK-Ay mice, a model of non-insulin dependent diabetes mellitus.

Chakraborty G, Thumpayil S, Lafontant DE, Woubneh W, Toney JH.

Lab Anim (NY). 2009 Nov;38(11):364-8. doi: 10.1038/laban1109-364.

PMID:
19847180
[PubMed - indexed for MEDLINE]
7.

Effect of long-term treatment with complete Freund's adjuvant on KK-Ay mouse, a model of non-insulin-dependent diabetes mellitus.

Muto Y, Satoh J, Muto G, Masuda T, Sagara M, Fukuzawa M, Miyaguchi S, Qiang XL, Sakata Y, Nakazawa T, Ikehata F, Toyota T.

Clin Immunol Immunopathol. 1997 Apr;83(1):53-9.

PMID:
9073536
[PubMed - indexed for MEDLINE]
8.

Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice.

Suto J, Matsuura S, Imamura K, Yamanaka H, Sekikawa K.

Eur J Endocrinol. 1998 Dec;139(6):654-61.

PMID:
9916873
[PubMed - indexed for MEDLINE]
Free Article
9.

Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice.

Hong L, Xun M, Wutong W.

J Pharm Pharmacol. 2007 Apr;59(4):575-82.

PMID:
17430642
[PubMed - indexed for MEDLINE]
10.

Increase in plasma fibrinogen and plasminogen activator inhibitor level in diabetic KK and KK-Ay mice.

Okazaki M, Udaka Y, Saito Y, Koseki H, Ohta S, Kikuchi T, Kamiya Y, Amagasa H, Oguchi K.

In Vivo. 2003 Jan-Feb;17(1):5-11.

PMID:
12655783
[PubMed - indexed for MEDLINE]
11.

Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.

Ito T, Tanimoto M, Yamada K, Kaneko S, Matsumoto M, Obayashi K, Hagiwara S, Murakoshi M, Aoki T, Wakabayashi M, Gohda T, Funabiki K, Maeda K, Horikoshi S, Tomino Y.

Nephrology (Carlton). 2006 Feb;11(1):29-35.

PMID:
16509929
[PubMed - indexed for MEDLINE]
12.

Antidiabetic effects of corosolic acid in KK-Ay diabetic mice.

Miura T, Ueda N, Yamada K, Fukushima M, Ishida T, Kaneko T, Matsuyama F, Seino Y.

Biol Pharm Bull. 2006 Mar;29(3):585-7.

PMID:
16508174
[PubMed - indexed for MEDLINE]
Free Article
13.

Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance.

Ohshima K, Mogi M, Jing F, Iwanami J, Tsukuda K, Min LJ, Higaki J, Horiuchi M.

Hypertension. 2012 Feb;59(2):493-9. doi: 10.1161/HYPERTENSIONAHA.111.183178. Epub 2011 Dec 19.

PMID:
22184328
[PubMed - indexed for MEDLINE]
Free Article
14.

Hypoglycemic activity of to-kai-san (Chinese medicines) in normal and KK-Ay mice.

Miura T, Noda M, Fukunaga T, Furuta K.

J Nutr Sci Vitaminol (Tokyo). 1997 Feb;43(1):11-7.

PMID:
9151237
[PubMed - indexed for MEDLINE]
15.

Antidiabetic effect of Nitobegiku, the herb Tithonia diversifolia, in KK-Ay diabetic mice.

Miura T, Nosaka K, Ishii H, Ishida T.

Biol Pharm Bull. 2005 Nov;28(11):2152-4.

PMID:
16272709
[PubMed - indexed for MEDLINE]
Free Article
16.

Increased methylmercury toxicity related to obesity in diabetic KK-Ay mice.

Yamamoto M, Yanagisawa R, Motomura E, Nakamura M, Sakamoto M, Takeya M, Eto K.

J Appl Toxicol. 2014 Aug;34(8):914-23. doi: 10.1002/jat.2954. Epub 2013 Nov 15.

PMID:
24243536
[PubMed - in process]
17.

Morphological analysis of the pancreas and liver in diabetic KK-Ay mice treated with zinc and oxovanadium complexes.

Moroki T, Yoshikawa Y, Yoshizawa K, Tsubura A, Yasui H.

Metallomics. 2014 Aug 20;6(9):1632-1638.

PMID:
24905743
[PubMed - as supplied by publisher]
18.

Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice.

Nakaoka F, Sasakawa Y, Yamamoto K, Nakao M, Nakamura M, Tong C, Fukuhama C, Kagawa K.

Life Sci. 2010 Mar 13;86(11-12):424-34. doi: 10.1016/j.lfs.2010.01.014. Epub 2010 Jan 25.

PMID:
20109472
[PubMed - indexed for MEDLINE]
19.

Improvement of glucose tolerance with immunomodulators on type 2 diabetic animals.

Zhu XP, Satoh J, Muto G, Muto Y, Sagara M, Takahashi K, Seino H, Hirai S, Masuda T, Tanaka S, Ishida H, Seino Y, Toyota T.

Biotherapy. 1996;9(4):189-97.

PMID:
9012538
[PubMed - indexed for MEDLINE]
20.

P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.

Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S.

Br J Pharmacol. 2009 Jul;157(5):724-35. doi: 10.1111/j.1476-5381.2009.00231.x. Epub 2009 May 5.

PMID:
19422369
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk